Table II.
Early results and clinical outcomes of ART cycles in two groups
| Group I (Diphereline) N=62 | Group II (Suprefact) N=64 | p value | |
|---|---|---|---|
| Ampoules of HMG | 25.6±12.1a | 25.9±8.5a | NS |
| Days of stimulation | 10.32±2.03a | 9.95±0.91a | NS |
| Retrieved oocytes | 12.11±6.32a | 9.43±6.4a | 0.02* |
| Oocytes in stage MII | 9.6±5.54a | 7.23±5.12a | 0.015* |
| Numbers of embryos | 6.1±3.9a | 4.73±3.45a | 0.04* |
| Numbers of transferred embryos | 2.31±0.733a | 2.29±0.726a | NS |
| Numbers of morphologically good embryos | 4.9±3.2a | 3.9±3.1a | NS |
| Clinical pregnancy rate [%] | 37.1 | 37.5 | NS |
| Miscarriage rate [%] | 8.7 | 8.33 | NS |
| Number of ICSI cycles, n(%) | 56 (90.3) | 58 (90.6) | NS |
a presented as mean±SD
NS-not significant
* Significant difference (p<0.05)